23andMe Holding Co. is a company within the Biotechnology and Consumer Healthcare category. 23andMe Holding Co. is a personal genomics and biotechnology company that provides direct-to-consumer genetic testing services. It offers detailed ancestry breakdowns and health predisposition reports based on DNA analysis from saliva samples. The company also maintains a large genetic research platform to aid in drug discovery and scientific study.
23andMe Holding Co. was founded in 2006 and is headquartered in South San Francisco, CA.
23andMe Holding Co. is rated Contender on the Optimly Brand Authority Index, a measure of how well AI models can accurately describe the brand. The exact score is locked for unclaimed profiles.
AI narrative accuracy for 23andMe Holding Co. is Moderate. Significant factual deltas detected.
AI models classify 23andMe Holding Co. as a Misread. Visible but inaccurate.
23andMe Holding Co. appeared in 5 of 6 sampled buyer-intent queries (83%). The brand is highly likely to appear for 'best DNA test' but faces risks for queries related to 'privacy' or 'medical accuracy' where third-party critiques are prioritized.
AI reliably captures the brand's core product offerings and market pioneer status but increasingly emphasizes security vulnerabilities and financial instability. The narrative has shifted from 'discovery' to 'data privacy risk' in many training datasets. Key gap: The gap between the brand's 'premium membership' marketing and the recent massive data breach/financial restructuring news which dominates search and AI retrieval but is absent from the brand's self-description.
Of 5 key facts verified about 23andMe Holding Co., 4 are well-documented (likely accurate across AI models), 1 have limited sourcing, and 0 are retrieval-dependent and may be inaccurate without live search.
The details of the 2023 data breach and its impact on user privacy terms are frequently summarized with varying degrees of accuracy or outdated information.
Buyers turn to 23andMe Holding Co. for Traditional Genealogy Research: Using public genealogy databases and archival records to trace family history without genetic data., Academic Research Studies: Participating in longitudinal health studies or medical trials that provide genomic results as a byproduct., among 2 documented problem areas.
Buyers evaluating 23andMe Holding Co. typically ask AI models about "best DNA test for health risks", "direct to consumer genetic testing companies", "personalized medicine based on genetics", and 4 similar queries.
23andMe Holding Co.'s main competitors are AncestryDNA, Helix, Myheritage Dna. According to AI models, these are the brands most frequently named alongside 23andMe Holding Co. in buyer-intent queries.
AI models suggest Academic Research Studies as alternatives to 23andMe Holding Co., typically when buyers ask for lower-cost, simpler, or more specialized options.
23andMe Holding Co.'s core products are Direct-to-consumer DNA kits for ancestry and health predispositions, 23andMe+ Premium subscription membership..
23andMe Holding Co. uses Subscription (for Premium) and One-time purchase (for kits).
23andMe Holding Co. serves Consumers interested in genealogy, health-conscious individuals, and biomedical researchers..
23andMe Holding Co. The only consumer DNA test with multiple FDA-cleared health reports and a massive research database powered by consented customer data.
Brand Authority Index (BAI) tier: Contender (exact score locked for unclaimed brands)
Archetype: Misread
https://optimly.ai/brand/23andme-holding-co
Last analyzed: April 10, 2026
Founded: 2006
Headquarters: South San Francisco, California, USA